Smart drug choices
We all have a stake in making sure workers receive the most effective health care for their condition, and prescription drugs are no exception. Drug prices can vary significantly and price does not necessarily correlate with efficacy.
As part of SAIF's mission to make workers' compensation insurance affordable, we are partnering with Oregon State University's College of Pharmacy to conduct a targeted prescriber education program. OSU will analyze physician prescribing patterns and contact physicians who may benefit from education about drug effectiveness. Their recommendations are voluntary.
The first class of drugs reviewed is sedative hypnotics. Additional classes will be posted as they are reviewed.
The first class of drugs reviewed is sedative hypnotics. Additional classes will be posted as they are reviewed.
Sedative hypnotics
- Zolpidem, Sonata and Lunesta have similar efficacy for sleep latency and total sleep time when used for <=4 weeks.1
- Withdrawals due to adverse events were similar.1
- Long-term use (>4 weeks) is discouraged because epidemiological data and recent FDA warnings suggest there are significant risks associated with long-term sedative use. 2, 3, 4
- Carson S, Yen PY, McDonagh MS. Drug Class Review on Newer Drugs for Insomnia. 2006.
- AHRQ Evidence Report 125 Manifestations & Management of Chronic Insomnia in Adults. June 2005.
- Glass J, Lanctôt KL, Herrmann N, Sproule BA, Busto UE, Sedative hypnotics in older people with insomnia: metaanalysis of risks and benefits. BMJ 2005; 331:1169.
- FDA News: Sleep Disorder (SedativeHypnotic) Drug Information. March 14, 2007
